Histopathological changes in anatomical distribution of inflammatory bowel disease in children: a retrospective cohort study

BMC Pediatrics

Wael El-Matary²  Donald Spady³  Sheena Sikora¹  Jessica Tsang¹ 

[1]Faculty of Medicine, University of Alberta, Edmonton, Canada

[2]Section of Pediatric Gastroenterology, Department of Pediatrics, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

[3]Department of Pediatric Epidemiology and Research, Faculty of Medicine, University of Alberta, Edmonton, Canada

关键词: Children;    Ulcerative colitis;    Crohn’s;    IBD;   

Others  :  1170633
DOI  :  10.1186/1471-2431-12-162

 received in 2012-01-02, accepted in 2012-10-08,  发布年份 2012

【 摘 要 】

Background

Anatomical progression of pediatric inflammatory bowel disease is under-reported. The aim of this work was to examine possible changes in the anatomical distribution of IBD in pediatric patients at diagnosis and at follow up.

Methods

In a retrospective cohort study, the medical records of children with inflammatory bowel disease were examined. Patients who had at least 2 endoscopic/colonoscopic examinations were included. Primary outcome was histopathological progression based on histopathological examination of biopsies taken during endoscopic and colonoscopic bowel examination. Factors predictive of disease progression were also examined.

Results

A total of 98 patients fulfilled inclusion criteria (49 female, 54 with ulcerative colitis, range 2 – 17 years, mean age at diagnosis was 10.6 years, SD ± 3.67), the mean duration of follow up was 32.9 months (range 0.1 – 60 months, SD ± 8.54). In the ulcerative colitis group, 41% had disease progression and none of the examined variables (age, gender, laboratory markers, growth and disease activity at diagnosis) appeared to effect disease progression. In the Crohn’s disease group, 75% had disease progression. Girls (OR = 0.13, 95% CI 0.02 – 0.79) and patients with high erythrocytic sedimentation rate (OR=0.942, 95% CI 0.894 – 0.99) were predictive for disease progression.

Conclusions

Despite maximum therapy, the majority of children with Crohn’s disease appeared to have histopathological disease progression. Female sex and high erythrocytic sedimentation rate seemed to be predictive for disease progression. None of the factors analyzed seemed predictive of disease progression in ulcerative colitis.

【 授权许可】

   
2012 Tsang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Working Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn’s and Colitis Foundation of America: Differentiating Ulcerative Colitis from Crohn’s Disease in Children and Young Adults: Report of a Working Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn’s and Colitis Foundation of America. J Pediatr Gastroenterol Nutr 2007, 44:653-674.
• [2]Ponsky T, Hindle A, Sandler A: Inflammatory Bowel Disease in the Pediatric Patient. Surg Clin N Am 2007, 87:643-658.
• [3]Limbergen JV, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, Smith L, Gillett PM, McGrogan P, Weaver LT, Bisset WM, Mahdi G, Arnott ID, Satsangi J, Wilson DC: Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel Disease. Gastroenterology 2008, 135:1114-1122.
• [4]Griffiths AM: Specificities of Inflammatory Bowel Disease in Childhood. Best Pract Res Clin Gastroenterol 2004, 18:509-523.
• [5]Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, Winter HS, Fain P, King C, Smith T, El-Serag HB: Children with Early-Onset Inflammatory Bowel Disease (IBD): Analysis of Pediatric IBD Consortium Registry. J Pediatr 2005, 146:35-40.
• [6]Geibel J, Longo W: Pediatric Inflammatory Bowel Disease. World J Gastroenterol 2006, 12:3204-3212.
• [7]Castro M, Papadatou B, Baldassare M, Balli F, Barabino A, Barbera C, Barca S, Barera G, Bascietto F, Berni Canani R, Calacoci M, Campanozzi A, Castellucci G, Catassi C, Colombo M, Covoni MR, Cucchiara S, D’Altilia MR, De Angelis GL, De Virgilis S, Di Ciommo V, Fontana M, Guariso G, Knafelz D, Lambertini A, Licciardi S, Lionetti P, Liotta L, Lombardi G, Maestri L, Martelossi S, Mastella G, Oderda G, Perini R, Pesce F, Ravelli A, Roggero P, Romano C, Rotolo N, Rutigliano V, Scotta S, Sferlazzas C, Staiano A, Ventura A, Zaniboni MG: Inflammatory Bowel Disease in Children and Adolescents in Italy: Data from the Pediatric National IBD Register (1996 – 2003). Inflamm Bowel Dis 2008, 14:1246-1252.
• [8]Paul T, Birnbaum A, Pal DK: Distinct Phenotype of Early Childhood Inflammatory Bowel Disease. J Clin Gastroenterol 2006, 40:583-586.
• [9]Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, Walters TD, Zachos M, Mamula P, Beaton DE, Steinhart AH, Griffiths AM: Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicentre study. Gastroenterology 2007, 133:423-432.
• [10]Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, Kugathasan S, Pfefferkorn M, Tolia V, Evans J, Treem W, Wyllie R, Rothbaum R, del Rosario J, Katz A, Mezoff A, Oliva-Hemker M, Lerer T, Griffiths A: Pediatric Inflammatory Bowel Disease Collaborative Research Group. Evaluation of pediatric disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005, 41:416-421.
• [11]Kugathasan S, Cohen S: Searching for New Clues in Inflammatory Bowel Disease: Tell Tales from Pediatric IBD Natural History Studies. J Gastroenterol 2008, 8:1038-1041.
• [12]Kundhal PS, Stormon MO, Zachos MD, Critch JN, Cutz E, Griffiths AM: Gastral antral biopsy in the differentiation of pediatric colitides. Am J Gastroenterol 2003, 98:557-561.
• [13]Freeman HJ: Long Term Natural History of Crohn’s Disease. World J Gastroenterol 2009, 15:1315-1318.
• [14]Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB: Natural History of Crohn’s Disease in a Population – Based Cohort from Cardiff (1986–2003): A Study of Changes in Medical Treatment and Surgical Resection Rates. Gut 2010, 59:1200-1206.
• [15]Vatn MH: Natural History and Complications of IBD. Curr Gastroenterol Rep 2009, 11:481-487.